Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 470-475

  Weidle, Paul J ^a,b   Ganea, Camelia E ^c   Irwin, Kathleen L ^a   Pieniazek, Danuta ^b   McGowan, Joseph P ^c   Olivo, Noemi ^c,d   Ramos, Artur ^b   Schable, Charles ^b   Lal, Renu B ^b   Holmberg, Scott D ^a   Ernst, Jerome A ^c,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c BRONX LEBANON HOSPITAL CENTER   (United States)

^d Visible Genetics   (United States)

^e Comm Research Initiative on AIDS ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; DRUG ABUSE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS TYPING;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEEDLE SHARING; NEW YORK CITY; PHYLOGENY; RISK-TAKING; SENTINEL SURVEILLANCE; SEROTYPING; SEXUAL BEHAVIOR; UNITED STATES; VARIATION (GENETICS);

EID: 0034005845     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315253     Document Type: Article

References (37)

1. Hu DH, Dondero TH, Rayfield MA, George R, et al. The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research, and prevention. JAMA 1996; 275:210-6.
2. Gao F, Yue L, Hill SC. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses 1994; 10:625-7.
3. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995; 346:1198-9.
4. Sullivan PS, Do AN, Robbins K, et al. Surveillance for variant strains of HIV: subtype G and group O HIV-1. JAMA 1997;278:292.
5. Brodine SK, Shaffer RA, Starkey MH, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999; 131:502-6.
6. Artenstein AW, Ohl CA, VanCott TC, Hegerich PA, Mascola JR. Transmission of HIV-1 subtype-E in the United States. JAMA 1996; 276:99-100.
7. Irwin KL, Pau CP, Lupo D, et al. Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high H1V prevalence: a sentinel site for monitoring HIV genetic diversity in North America. J Infect Dis 1997; 176:1629-33.
8. Flores I, Pieniazek D, Morán N, et al. HIV-1 subtype F in single and dual infections in Puerto Rico: a potential sentinel site for monitoring novel genetic HIV variants in North America. Emerg Infect Dis 1999; 5:481-3.
9. Pau CP, Hu DJ, Spruill C, et al. Surveillance for human immunodeficiency virus type 1 group O infections in the United States. Transfusion 1996; 36:398-400.
10. Janini LM, Pieniazek D, Peralta JM, et al. Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes 1996; 13:69-81.
11. Tanuri A, Swanson P, Devare S, et al. HIV-1 subtypes among blood donors from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:60-6.
12. Pieniazek D, Yang C, Lal RB. Phylogenetic analysis of gp41 envelope of HIV-1 groups M, N, and O strains provides an alternate region for subtype determination. In: Korber B, Foley B, McCutchan F, et al., eds. Human retroviruses and AIDS. Los Alamos, NM: Los Alamos National Laboratory, 1998:111-112-7 (http://hiv-web.lanl.gov/HTML/reviews/reviews.html).
13. Yang C, Pieniazek D, Owen SM, et al. Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and group O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999; 37:2581-6.
14. Ou CY, Ciesielski C, Myers G, et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256:1165-71.
15. Larsen N, Olsen GJ, Maidak BL, et al. The ribosomal database project. Nucleic Acids Res 1993; 21:3021-3.
16. Felsenstein J. PHYLIP phylogeny inference package (version 3.2). Cladistics 1989; 5:164-6.
17. Pau CP, Lee-Thomas S, Auwanit W, et al. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993; 7:337-40.
18. Rayfield MA, Sullivan P, Bandea CI, et al. HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis 1996; 2:209-12.
19. Montpetit M. HIV-1 subtype A in Canada. AIDS Res Hum Retroviruses 1995; 11:1421-2.
20. Marquina S, Leitner T, Rabinovich RD, Benetucci J, Libonatti O, Albert J. Coexistence of subtypes B, F, and a B/F env recombinant of HIV type 1 in Buenos Aires, Argentina. AIDS Res Hum Retroviruses 1996; 12:1651-4.
21. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997; 11:199-202.
22. Arnold C, Barlow KL, Parry JV, Clewley JP. At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res Hum Retroviruses 1995; 11:427-9.
23. Clewley JP, Arnold C, Barlow KL, Grant PR, Parry JV. Diverse HIV-1 genetic-subtypes in UK. Lancet 1996; 347:1487.
24. De Souza M, Song MS, Carr JK, et al. HIV-1 subtypes A and B isolated from the Republic of Korea. AIDS 1997; 11:389-91.
25. Fransen K, Buve A, Nkengasong JN, Laga M, van der Groen G. Long-standing presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996; 347:1403.
26. Lukashov VV, Kuiken CL, Boer K, Goudsmit J. HIV type 1 subtypes in the Netherlands circulating among women originating from AIDS-endemic regions. AIDS Res Hum Retroviruses 1996; 12:951-3.
27. Dietrich U, Ruppach H, Gehring S, et al. Large proportion of non-B subtypes and presence of zidovudine resistance mutations among German seroconverters. AIDS 1997; 11:1532-3.
28. Gehring S, Maayan S, Ruppach H, et al. Molecular epidemiology of HIV in Israel. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:296-303.
29. Lasky M, Perret J, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997; 11:43-51.
30. Artenstein AW, Coppola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into the Western Hemisphere. Lancet 1995; 346:1197-8.
31. Centers for Disease Control and Prevention. Identification of HIV-1, group O infection - Los Angeles County, California, 1996. MMWR Morb Mortal Wkly Rep 1996; 45:561-5.
32. Sabino EC, Diaz RS, Brigido LF, et al. Distribution of HIV-1 subtypes seen in an AIDS clinic in São Paulo City, Brazil. AIDS 1996; 10:1579-84.
33. Morgado MG, Guimaraes ML, Gripp CBG, et al. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:488-94.
34. Apetrei C, Loussert-Ajaka I, Descamps D, et al. Lack of screening test sensitivity during HIV-1 non-B subtype seroconversions. AIDS 1996; 10: F57-60.
35. Girarg M, Yue L, Barre-Sinoussi F, et al. Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virol 1996; 70:8229-33.
36. Palmer S, Alaeus A, Albert J, Cox S. Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses 1998; 14:157-62.
37. Schable C, Zekung L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344:1333-4.